FDA issued a Warning Letter to Actelion Pharmaceuticals U.S., Inc. on 9/14/2010 for a previous inspection.
483 Actelion Pharmaceuticals U.S. Feb 2014

483 Actelion Pharmaceuticals U.S. Feb 2014

Anh Lac FDA$119.00 - Available Now

FDA investigators audited the Actelion Pharmaceuticals U.S. - South San Francisco, CA, United States facility and issued inspectional observations (via FDA 483) on 12 Feb 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Feb 2014
  • Location: South San Francisco, United States
  • FEI: 3003498827
Add To Cart